ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Ohio State to study center expansion.

September 26, 2003

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

June 14, 2013

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

May 8, 1992

IOM Report Lists Cancer CER Priorities

July 3, 2009